SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-487204"
 

Search: onr:"swepub:oai:DiVA.org:uu-487204" > Benefit of Primary ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors : A Propensity-Score Matched Cohort Study

Kjaer, Josefin (author)
Uppsala universitet,Endokrinkirurgi
Clancy, Thomas E. (author)
Thornell, Anders (author)
show more...
Andersson, Niklas (author)
Hellman, Per (author)
Uppsala universitet,Endokrinkirurgi
Crona, Joakim (author)
Uppsala universitet,Endokrin tumörbiologi
Welin, Staffan (author)
Uppsala universitet,Onkologisk endokrinologi
Sulciner, Megan (author)
Powell, Brittany (author)
Brais, Lauren (author)
Astone, Kristina (author)
Baddoo, William (author)
Doherty, Gerhard (author)
Chan, Jennifer A. (author)
Norlén, Olov (author)
Uppsala universitet,Endokrinkirurgi
Stålberg, Peter (author)
Uppsala universitet,Endokrinkirurgi
show less...
 (creator_code:org_t)
2022-03
2022
English.
In: Annals of Surgery Open. - : Wolters Kluwer. - 2691-3593. ; 3:1
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective: To determine the association of primary tumor resection in stage IV pancreatic neuroendocrine tumors (Pan-NET) and survival in a propensity-score matched study.Background: Pan-NET are often diagnosed with stage IV disease. The oncologic benefit from primary tumor resection in this scenario is debated and previous studies show contradictory results.Methods: Patients from 3 tertiary referral centers from January 1, 1985, through December 31, 2019: Uppsala University Hospital (Uppsala, Sweden), Sahlgrenska University Hospital (Gothenburg, Sweden), and Brigham and Women’s Hospital/Dana-Farber Cancer Institute (Boston, USA) were assessed for eligibility. Patients with sporadic, grade 1 and 2, stage IV pan-NET, with baseline 2000–2019 were divided between those undergoing primary tumor resection combined with oncologic treatment (surgery group [SG]), and those who received oncologic treatment without primary tumor resection (non-SG). A propensity-score matching was performed to account for the variability in the extent of metastatic disease and comorbidity. Primary outcome was overall survival.Results: Patients with stage IV Pan-NET (n = 733) were assessed for eligibility, 194 were included. Patients were divided into a SG (n = 65) and a non-SG (n = 129). Two isonumerical groups with 50 patients in each group remained after propensity-score matching. The 5-year survival was 65.4% (95% CI, 51.5-79.3) in the matched SG and 47.8% (95% CI, 30.6-65.0) in the matched non-SG (log-rank, P = 0.043).Conclusions: Resection of the primary tumor in patients with stage IV Pan-NET and G1/G2 grade was associated with prolonged overall survival compared to nonoperative management. A surgically aggressive regime should be considered where resection is not contraindicated.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Kirurgi
Surgery

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view